Cumberland Pharmaceuticals (CPIX) Operating Leases (2019 - 2025)
Historic Operating Leases for Cumberland Pharmaceuticals (CPIX) over the last 9 years, with Q3 2025 value amounting to $5.0 million.
- Cumberland Pharmaceuticals' Operating Leases fell 726.84% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 726.84%. This contributed to the annual value of $5.3 million for FY2024, which is 616.71% down from last year.
- According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Operating Leases is $5.0 million, which was down 726.84% from $5.1 million recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Operating Leases ranged from a high of $5.8 million in Q2 2023 and a low of $229605.0 during Q3 2022
- Moreover, its 5-year median value for Operating Leases was $5.0 million (2025), whereas its average is $3.7 million.
- In the last 5 years, Cumberland Pharmaceuticals' Operating Leases tumbled by 8265.55% in 2022 and then surged by 239262.34% in 2023.
- Over the past 5 years, Cumberland Pharmaceuticals' Operating Leases (Quarter) stood at $1.1 million in 2021, then surged by 349.11% to $4.8 million in 2022, then rose by 18.6% to $5.6 million in 2023, then dropped by 6.17% to $5.3 million in 2024, then decreased by 5.65% to $5.0 million in 2025.
- Its Operating Leases was $5.0 million in Q3 2025, compared to $5.1 million in Q2 2025 and $5.2 million in Q1 2025.